185 Bifunctional inhibitor/lipid-transfer protein/seed storage 2S albumin-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 3 | 6.3 | 0.48× | q = 0.14 | |
| Hydrocarbons | 1 | 0.1 | 11× | not tested | |
| Lipids and lipid-like molecules | 10 | 1.4 | 7.01× | not tested | |
| Organic nitrogen compounds | 1 | 0.4 | 2.45× | not tested | |
| Organic oxygen compounds | 2 | 2.6 | 0.78× | not tested | |
| Homogeneous non-metal compounds | 2 | 2.8 | 0.72× | not tested | |
| Organic acids and derivatives | 1 | 2.0 | 0.50× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 3.5 | 0.28× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08231 | MYR | Myristic acid | 7 |
| DB03017 | DAO | Lauric acid | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 4 |
| DB03193 | STE | Stearic acid | 3 |
| DB03438 | PGM | Lysophosphatidylglycerol | 3 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB04257 | PAM | Palmitoleic Acid | 2 |
| DB00132 | LNL | alpha-Linolenic acid | 1 |
| DB01707 | LAP | L-Alfa-Lysophosphatidylcholine, Lauroyl | 1 |
| DB01992 | COA | Coenzyme A | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
| DB02304 | E2P | Prostaglandin B2 | 1 |
| DB02955 | RCL | Ricinoleic acid | 1 |
| DB03600 | DKA | Capric acid | 1 |
| DB04540 | CLR | Cholesterol | 1 |
| DB11220 | O8N | Octacosanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 17 |
| MYR | MYRISTIC ACID | 7 |
| DAO | LAURIC ACID | 6 |
| ZNmetal | ZINC ION | 5 |
| CL | CHLORIDE ION | 4 |
| 29N | 1,1',1''-(1,3,5-triazinane-1,3,5-triyl)tripropan-1-one | 3 |
| NAmetal | SODIUM ION | 3 |
| PGM | 1-MYRISTOYL-2-HYDROXY-SN-GLYCERO-3-[PHOSPHO-RAC-(1-GLYCEROL)] | 3 |
| PLM | PALMITIC ACID | 3 |
| STE | STEARIC ACID | 3 |
| ASY | (12E)-10-oxooctadec-12-enoic acid | 2 |
| HP6 | HEPTANE | 2 |
| LPC | [1-MYRISTOYL-GLYCEROL-3-YL]PHOSPHONYLCHOLINE | 2 |
| PAM | PALMITOLEIC ACID | 2 |
| TFA | trifluoroacetic acid | 2 |
| CLR | CHOLESTEROL | 1 |
| COA | COENZYME A | 1 |
| CXS | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID | 1 |
| DKA | DECANOIC ACID | 1 |
| E2P | PROSTAGLANDIN B2 | 1 |